ProCE Banner Activity

plasmaMATCH (CRUK/15/010): Evaluation of Circulating Tumor DNA Testing to Direct Targeted Therapies in Patients with Advanced Breast Cancer

Slideset Download
Conference Coverage
Patients with advanced breast cancer and rare mutations identified by ctDNA testing responded to matched targeted therapies.

Released: December 20, 2019

Expiration: December 18, 2020

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Daiichi Sankyo, Inc.

Genentech TEXT Only

Merck Sharp & Dohme Corp.

Puma Biotechnology, Inc.

Seagen